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Introduction
Systemic lupus erythematosus (SLE), a chronic autoimmune 
disease, is characterized by multi-systemic impairment and, 
respectively, leads to decreased quality of life (QoL) in patients. 
Arterial Hypertension (AHT) is a common commorbidity in 
patients with SLE, with the potential to affect QoL. Respectively, 
studying the QoL in the case of the association of SLE with AHT 
is a challenge. 
Purpose
To study Quality of Life in patients with Systemic lupus 
erythematosus and arterial hypertension.
 
Material and methods
Case-control study, that included 2 groups of patients: SLE 
without AHT - group 1, SLE with AHT - group 2. QoL was 
quantified by SF-8 questionnaire, total SF-8 (SF-8t) were 
calculated, Mental SF-8 (SF-8m) and physical SF-8 (SF-8f).
Results
The study included 23 patients with SLE (SLICC criteria, 2012). 
The F: M ratio was 14: 1, the mean age was 41.2 ± 12.7 years. 
The duration of the disease was  80.1 ± 42.5 months, SLEDAI 
activity of 8.0 ± 7.8 points.
• Group 1 - 11 patients with SLE without AHT,




 Patients with SLE was observed to have  decreased QoL indices 
from  the physical and mental components. Arterial 
Hypertension, is  a comorbidity frequently associated with 
patients with SLE, which negatively influences the physical 
component of QoL, which implies the need for targeted 
management of BP values in these patients.
